Ganesan L - Search Results

1

Pharmacological Inhibition of Protein Lipidation.

Ganesan L, Levental I. Ganesan L, et al. J Membr Biol. 2015 Dec;248(6):929-41. doi: 10.1007/s00232-015-9835-4. Epub 2015 Aug 18. J Membr Biol. 2015. PMID: 26280397 Free PMC article. Review.

2

Plasma membranes are asymmetric in lipid unsaturation, packing and protein shape.

Lorent JH, Levental KR, Ganesan L, Rivera-Longsworth G, Sezgin E, Doktorova M, Lyman E, Levental I. Lorent JH, et al. Among authors: ganesan l. Nat Chem Biol. 2020 Jun;16(6):644-652. doi: 10.1038/s41589-020-0529-6. Epub 2020 May 4. Nat Chem Biol. 2020. PMID: 32367017 Free PMC article.

3

Author Correction: Plasma membranes are asymmetric in lipid unsaturation, packing and protein shape.

Lorent JH, Levental KR, Ganesan L, Rivera-Longsworth G, Sezgin E, Doktorova M, Lyman E, Levental I. Lorent JH, et al. Among authors: ganesan l. Nat Chem Biol. 2020 Jun;16(6):710. doi: 10.1038/s41589-020-0564-3. Nat Chem Biol. 2020. PMID: 32415286

4

Click-Chemistry Based High Throughput Screening Platform for Modulators of Ras Palmitoylation.

Ganesan L, Shieh P, Bertozzi CR, Levental I. Ganesan L, et al. Sci Rep. 2017 Jan 23;7:41147. doi: 10.1038/srep41147. Sci Rep. 2017. PMID: 28112226 Free PMC article.

5

Mutations in alpha-tubulin confer dinitroaniline resistance at a cost to microtubule function.

Ma C, Li C, Ganesan L, Oak J, Tsai S, Sept D, Morrissette NS. Ma C, et al. Among authors: ganesan l. Mol Biol Cell. 2007 Dec;18(12):4711-20. doi: 10.1091/mbc.e07-04-0379. Epub 2007 Sep 19. Mol Biol Cell. 2007. PMID: 17881728 Free PMC article.

6

Secondary mutations correct fitness defects in Toxoplasma gondii with dinitroaniline resistance mutations.

Ma C, Tran J, Li C, Ganesan L, Wood D, Morrissette N. Ma C, et al. Among authors: ganesan l. Genetics. 2008 Oct;180(2):845-56. doi: 10.1534/genetics.108.092494. Epub 2008 Sep 9. Genetics. 2008. PMID: 18780736 Free PMC article.

7

Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia.

Vu TT, Kim K, Manna M, Thomas J, Remaily BC, Montgomery EJ, Costa T, Granchie L, Xie Z, Guo Y, Chen M, Castillo AMM, Kulp SK, Mo X, Nimmagadda S, Gregorevic P, Owen DH, Ganesan LP, Mace TA, Coss CC, Phelps MA. Vu TT, et al. Among authors: ganesan lp. Pharmacol Res. 2024 Jan;199:107048. doi: 10.1016/j.phrs.2023.107048. Epub 2023 Dec 23. Pharmacol Res. 2024. PMID: 38145833 Free PMC article.

8

Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors.

Guo Y, Remaily BC, Thomas J, Kim K, Kulp SK, Mace TA, Ganesan LP, Owen DH, Coss CC, Phelps MA. Guo Y, et al. Among authors: ganesan lp. Clin Cancer Res. 2024 Mar 1;30(5):942-958. doi: 10.1158/1078-0432.CCR-23-1683. Clin Cancer Res. 2024. PMID: 37921739 Review.

9

The therapeutic effects of gingival mesenchymal stem cells and their exosomes in a chimeric model of rheumatoid arthritis.

Bruckner S, Capria VM, Zeno B, Leblebicioglu B, Goyal K, Vasileff WK, Awan H, Willis WL, Ganesan LP, Jarjour WN. Bruckner S, et al. Among authors: ganesan lp. Arthritis Res Ther. 2023 Oct 26;25(1):211. doi: 10.1186/s13075-023-03185-6. Arthritis Res Ther. 2023. PMID: 37885040 Free PMC article.

10

Pseudomonas aeruginosa pulmonary infection results in S100A8/A9-dependent cardiac dysfunction.

Kumar N, Pestrak MJ, Wu Q, Ahumada OS, Dellos-Nolan S, Saljoughian N, Shukla RK, Mitchem CF, Nagareddy PR, Ganesan LP, William LP, Wozniak DJ, Rajaram MVS. Kumar N, et al. Among authors: ganesan lp. PLoS Pathog. 2023 Aug 25;19(8):e1011573. doi: 10.1371/journal.ppat.1011573. eCollection 2023 Aug. PLoS Pathog. 2023. PMID: 37624851 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page